seattle genetics inc
(SGEN:Consolidated Issue Listed on NASDAQ Global Select )
Nancy A. Simonian M.D.
Director and Chairman of Nominating & Corporate Governance Committee, Seattle Genetics, Inc.
|Age||Total Calculated Compensation||This person is connected to 26 board members in 2 different organizations across 4 different industries.|
See Board Relationships
Dr. Nancy A. Simonian, M.D., has been the Chief Executive Officer at Syros Pharmaceuticals Inc. since April 2013. Dr. Simonian served as the Chief Medical Officer of Clinical, Medical & Regulatory Affairs at Millennium Pharmaceuticals, Inc. She served as the Chief Medical Officer of Millennium Pharmaceuticals Inc. since 2006. While at Millennium, Dr. Simonian has built a strong clinical development organization which effectively executes on a diverse pipeline of product ...
21823 30th Drive SEPhone: 425-527-4000
Bothell, Washington 98021
Board Members Memberships*
Former Director and Member of Science Committee
Director and Chairman of Nominating & Corporate Governance Committee
Chief Executive Officer and Director
University of Pennsylvania - School of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|